NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Alvotech (“Alvotech” or the “Company”) (NASDAQ:ALVO). The investigation concerns whether the Company may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On November 3, 2025, the Company received a complete response letter (“CRL”) from the FDA for its biologics license application for AVT05. The CRL ...